Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo

Girentuximab (cG250) targets carbonic anhydrase IX (CAIX), a protein which is expressed on the surface of most renal cancer cells (RCCs). cG250 labeled with <sup>177</sup>Lu has been used in clinical trials for radioimmunotherapy (RIT) of RCCs. In this work, an extensive characterization...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tais Basaco (Autor), Stefanie Pektor (Autor), Josue M. Bermudez (Autor), Niurka Meneses (Autor), Manfred Heller (Autor), José A. Galván (Autor), Kayluz F. Boligán (Autor), Stefan Schürch (Autor), Stephan von Gunten (Autor), Andreas Türler (Autor), Matthias Miederer (Autor)
Format: Knjiga
Izdano: MDPI AG, 2018-11-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno